Home > Cashflow Statement > MANKIND PHARMA

MANKIND PHARMA
Cash Flow from Operating Activities

    Back to Cashflow Statement
MANKIND PHARMA is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
COMMUNITY POLL
for MANKIND PHARMA
Please provide your vote to see the results

MANKIND PHARMA Last 5 Year Cash Flow from Operating Activities History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Cash Flow from Operating Activities ₹2,152 Cr₹1,813 Cr₹920 Cr₹1,137 Cr₹1,072 Cr

What is the latest Cash Flow from Operating Activities ratio of MANKIND PHARMA ?

The latest Cash Flow from Operating Activities ratio of MANKIND PHARMA is ₹2,152 Cr based on Mar2024 Consolidated results.
Year Cash Flow from Operating Activities
Mar2024₹2,152 Cr
Mar2023₹1,813 Cr
Mar2022₹920 Cr
Mar2021₹1,137 Cr
Mar2020₹1,072 Cr

How is Cash Flow from Operating Activities of MANKIND PHARMA Trending?

Years Cash Flow from Operating Activities % Change
Mar2024 ₹2,152 Cr
18.70
Mar2023 ₹1,813 Cr
97.15
Mar2022 ₹920 Cr
-19.12
Mar2021 ₹1,137 Cr
6.07
Mar2020 ₹1,072 Cr -

Compare Cash Flow from Operating Activities of peers of MANKIND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANKIND PHARMA ₹99,979.2 Cr 2.1% 3.7% 9.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹416,393.0 Cr -2.8% 7.6% 8.4% Stock Analytics
DIVIS LABORATORIES ₹153,258.0 Cr -2.3% 0.8% 72.7% Stock Analytics
CIPLA ₹116,434.0 Cr -5.4% -1.5% 0.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹109,474.0 Cr -0.8% 6.8% 25.6% Stock Analytics
DR REDDYS LABORATORIES ₹95,465.9 Cr -5.5% 1.6% -5.1% Stock Analytics


MANKIND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MANKIND PHARMA

2.1%

3.7%

9.5%

SENSEX

0.7%

4%

6.3%


You may also like the below Video Courses